CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results